Aseptic Stethoscope Barriers Prevent C difficile Transmission In Vitro

Objective: To evaluate whether Clostridioides (formerly Clostridium) difficile–contaminated stethoscope diaphragms remained aseptic by the placement of an aseptic diaphragm barrier. Methods: On November 1, 2019, fresh cultures of C difficile were diluted to 107 colony-forming units (CFU)/mL and used...

Full description

Bibliographic Details
Main Authors: W. Frank Peacock, MD, Sarathi Kalra, MD, Rajiv S. Vasudevan, Francesca Torriani, MD
Format: Article
Language:English
Published: Elsevier 2021-02-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2542454820302022
_version_ 1818857224780382208
author W. Frank Peacock, MD
Sarathi Kalra, MD
Rajiv S. Vasudevan
Francesca Torriani, MD
author_facet W. Frank Peacock, MD
Sarathi Kalra, MD
Rajiv S. Vasudevan
Francesca Torriani, MD
author_sort W. Frank Peacock, MD
collection DOAJ
description Objective: To evaluate whether Clostridioides (formerly Clostridium) difficile–contaminated stethoscope diaphragms remained aseptic by the placement of an aseptic diaphragm barrier. Methods: On November 1, 2019, fresh cultures of C difficile were diluted to 107 colony-forming units (CFU)/mL and used to inoculate 16 stethoscope diaphragms; 8 had an aseptic diaphragm barrier applied and 8 served as nonbarrier controls. Contaminated stethoscopes were anaerobically incubated, then swabbed at 15 and 30 minutes, 2 and 4 hours, and 1, 2, 3, and 7 days after inoculation and subsequently plated onto blood, chocolate, and cycloserine-cefoxitin fructose agar. Plates were incubated for 48 hours and on November 9, 2019, the resulting colonies were manually counted. Statistical analyses (RStudio, version 1.0.153) used analysis of variance with post hoc Tukey honestly significant difference. Results: Overall, mean colony count was 33 CFU on stethoscopes without barriers vs zero on those with barriers (P≤.05). Growth was greatest at 48 hours, with colony counts as high as 160 CFU. The presence of the barrier resulted in no growth in 100% of stethoscope diaphragms for up to 1 week. Conclusion: We found that stethoscope diaphragm barriers provide an aseptic patient contact point, thus reducing the potential for transmission of C difficile during the physical examination. In critical care environments, in which many hospitals use acoustically inferior disposable stethoscopes, the option of a disposable aseptic stethoscope barrier may allow high-quality auscultation while reducing the potential for pathogen transmission.
first_indexed 2024-12-19T08:37:00Z
format Article
id doaj.art-c9bbec503d4844f3a0692b9390932e9a
institution Directory Open Access Journal
issn 2542-4548
language English
last_indexed 2024-12-19T08:37:00Z
publishDate 2021-02-01
publisher Elsevier
record_format Article
series Mayo Clinic Proceedings: Innovations, Quality & Outcomes
spelling doaj.art-c9bbec503d4844f3a0692b9390932e9a2022-12-21T20:29:01ZengElsevierMayo Clinic Proceedings: Innovations, Quality & Outcomes2542-45482021-02-0151103108Aseptic Stethoscope Barriers Prevent C difficile Transmission In VitroW. Frank Peacock, MD0Sarathi Kalra, MD1Rajiv S. Vasudevan2Francesca Torriani, MD3Department of Emergency Medicine, Baylor College of Medicine, Houston, TX; Correspondence: Address to W. Frank Peacock, MD, Ben Taub General Hospital, Emergency Department, 1504 Taub Loop, Houston, TX 77030.Department of Emergency Medicine, University of South Alabama, Mobile, ALDepartment of Medicine, University of California San Diego School of Medicine, San Diego, CADepartment of Medicine, University of California San Diego School of Medicine, San Diego, CAObjective: To evaluate whether Clostridioides (formerly Clostridium) difficile–contaminated stethoscope diaphragms remained aseptic by the placement of an aseptic diaphragm barrier. Methods: On November 1, 2019, fresh cultures of C difficile were diluted to 107 colony-forming units (CFU)/mL and used to inoculate 16 stethoscope diaphragms; 8 had an aseptic diaphragm barrier applied and 8 served as nonbarrier controls. Contaminated stethoscopes were anaerobically incubated, then swabbed at 15 and 30 minutes, 2 and 4 hours, and 1, 2, 3, and 7 days after inoculation and subsequently plated onto blood, chocolate, and cycloserine-cefoxitin fructose agar. Plates were incubated for 48 hours and on November 9, 2019, the resulting colonies were manually counted. Statistical analyses (RStudio, version 1.0.153) used analysis of variance with post hoc Tukey honestly significant difference. Results: Overall, mean colony count was 33 CFU on stethoscopes without barriers vs zero on those with barriers (P≤.05). Growth was greatest at 48 hours, with colony counts as high as 160 CFU. The presence of the barrier resulted in no growth in 100% of stethoscope diaphragms for up to 1 week. Conclusion: We found that stethoscope diaphragm barriers provide an aseptic patient contact point, thus reducing the potential for transmission of C difficile during the physical examination. In critical care environments, in which many hospitals use acoustically inferior disposable stethoscopes, the option of a disposable aseptic stethoscope barrier may allow high-quality auscultation while reducing the potential for pathogen transmission.http://www.sciencedirect.com/science/article/pii/S2542454820302022
spellingShingle W. Frank Peacock, MD
Sarathi Kalra, MD
Rajiv S. Vasudevan
Francesca Torriani, MD
Aseptic Stethoscope Barriers Prevent C difficile Transmission In Vitro
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
title Aseptic Stethoscope Barriers Prevent C difficile Transmission In Vitro
title_full Aseptic Stethoscope Barriers Prevent C difficile Transmission In Vitro
title_fullStr Aseptic Stethoscope Barriers Prevent C difficile Transmission In Vitro
title_full_unstemmed Aseptic Stethoscope Barriers Prevent C difficile Transmission In Vitro
title_short Aseptic Stethoscope Barriers Prevent C difficile Transmission In Vitro
title_sort aseptic stethoscope barriers prevent c difficile transmission in vitro
url http://www.sciencedirect.com/science/article/pii/S2542454820302022
work_keys_str_mv AT wfrankpeacockmd asepticstethoscopebarrierspreventcdifficiletransmissioninvitro
AT sarathikalramd asepticstethoscopebarrierspreventcdifficiletransmissioninvitro
AT rajivsvasudevan asepticstethoscopebarrierspreventcdifficiletransmissioninvitro
AT francescatorrianimd asepticstethoscopebarrierspreventcdifficiletransmissioninvitro